00
Days
00
Hrs
00
Min
00
Sec
Submit Your Paper

Synthesis and Molecular Docking Studies of Pyrazolylpyrazoline-Clubbed Triazole and Tetrazoles.

Authors

Dr. Kokane Balaji Digambar

Department of Chemistry Shri Kumarswami Mahavidyalaya, Ausa Dist. Latur (MS) 413520. (IN)

Article Information

DOI: 10.51583/IJLTEMAS.2025.1411000025

Subject Category: Organic Chemistry

Volume/Issue: 14/11 | Page No: 256-262

Publication Timeline

Submitted: 2025-12-04

Published: 2025-12-03

Abstract

To increase the antitubercular potency, we synthesized a series of novel pyrazolylpyrazoline derivatives (9a−n) using the one-pot multi component reaction of the substituted hetero aryl aldehyde (3a,b), 2-acetyl pyrrole/thiazole (4a,b),and substituted hydrazine hydrates(5−8) in the presence of base KOH as a catalyst in ethanol as the solvent at room temperature. Substituted hetero aryl aldehyde (3a,b) was synthesized from 5-chloro-3-methyl-1-phenyl-1H-pyrazole-4 methyl-carbaldehyde  by treatment with 4-amino triazole/5-amino tetrazole. 5-Chloro-4-(1,3-dioxolan-2-yl)-3-methyl-1-phenyl-1H-pyrazole (1) was reacted with 4H-1,2,4-triazol-4-amine (a) and 1H-tetrazol-5-amine (b) in the presence of K2CO3 in 1,4-dioxane  at 80 °C for 13 h. Similarly, 5-((4H-1,2,4-triazol-4-yl)amino)-3-methyl-1-phenyl-1H-pyrazole-4-carbaldehyde (3a) and 5-((1H-tetrazol-5-yl)amino)-3-methyl-1-phenyl-1H-pyrazole-4-carbaldehyde (3b) were achieved further reacted with 2-acetyle thiophene (4a) and 2-acetyle furan (4b) and substituted hydrazide derivatives (5–8) in the presence of 50% ethanolic KOH solution at room temperature All of the compounds were tested against Mycobacteriumtuberculosis H37Rv, Theoretical results were in good accord with the observed experimental values. The docking score of the most active compound 9n was found good Glide energy .

Keywords

K2CO3 in 1,4-dioxane, Pyrazolylpyrazoline

Downloads

References

1. TB Reports. https://www.who.int/teams/global-tuberculosis programme/tb-reports(accessedSept5,2021). [Google Scholar] [Crossref]

2. Lange,C.;Dheda,K.;Chesov,D.;Mandalakas,A.M.;Udwadia, Z.;Horsburgh,C. R.Management of Drug-Resistant Tuberculosis. Lancet2019,394,953−966. [Google Scholar] [Crossref]

3. Desai,N.C.;Bhatt,K.;Monapara, J.;Pandit,U.;Khedkar,V.M. Antit ACS Omega 2021,6,28270−28284. [Google Scholar] [Crossref]

4. Dai, H.; Huang, M.; Qian, J.; Liu, J.; Meng, C.; Li, Y.; Ming, G.; Zhang, T.; Wang, S.; Shi, Y.; Yao, Y.; Ge, S.; Zhang, Y.; Ling, Eur. J. Med. Chem. 2019, 166, 470−479. [Google Scholar] [Crossref]

5. Ghasempour, L.; Asghari, S.; Tajbakhsh, M.; Mohseni, M. Chem. Biodiversity 2021, 18, No. e2100197. [Google Scholar] [Crossref]

6. Negri, A.; Javidnia, P.; Mu, R.; Zhang, X. Med. Chem. Res. 2019, 28, 169−181. [Google Scholar] [Crossref]

7. Liu, J.-J.; Zhao, M.; Zhang, X.; Zhao, X.; Zhu, H.-L. Med. Chem. 2013, 13, 1957−1966. [Google Scholar] [Crossref]

8. Liu, X. R.; Wu, H.; He, Z. Y.; Ma, Z. Q.; Feng, J. T.; Molecules 2014, 19, 14036−14051. [Google Scholar] [Crossref]

9. Mor, S.; Khatri, M.; punia, R.; Sindhu, S. Med. Chem. 2022, 22, 115−163. [Google Scholar] [Crossref]

10. Cuartas, V.; Robledo, S. M.; Vélez, I. D.; Crespo, M. D. P.; Sortino, M.; Zacchino, S.; Nogueras, M.; Cobo, J.; Upegui, Y.; Pineda, T.; Arch. Pharm. 2020, 353, No. e1900351. [Google Scholar] [Crossref]

11. Kumar, G.; Siva Krishna, V.; Sriram, D.; Jachak, S. Arch. Pharm. 2020, 353, No. 2000077. [Google Scholar] [Crossref]

12. Ismail, A. H.; Abdula, A. M.; Tomi, I. H.; Al-Daraji, A. H.; Baqi, Med. Chem. 2021, 17, 462−473. [Google Scholar] [Crossref]

13. Matiadis, D.; Sagnou, M. Int. J. Mol. Sci. 2020, 21, 1−41. [Google Scholar] [Crossref]

14. Desai, N. C.; Vaja, D. V.; Monapara, J. D.; Manga, V.; Vani, T. J. Heterocycl. Chem. 2021, 58, 737−750. [Google Scholar] [Crossref]

15. Zala, M. J.; Vora, J. J.; Khedkar, V. M. Russ. J. Org. Chem. 2021, 57, 2054−2062. [Google Scholar] [Crossref]

16. Zala, M. J.; Vora, J. J. Russ. J. Org. Chem. 2021, 57, 1725−1732. [Google Scholar] [Crossref]

17. Amir, M.; Kumar, H.; Khan, S. A. Bioorg. Med. Chem. Lett. 2008, 18, 918−922. [Google Scholar] [Crossref]

18. Liao, L.; Jiang, C.; Chen, J.; Shi, J.; Li, X.; Wang, Y.; Wen, J.; Zhou, S.; Liang, J.; Lao, Y.; Zhang, J. Med. Chem. 2020, 190, No. 112114. [Google Scholar] [Crossref]

19. Pokuri, S.; Singla, R.; Bhat, V.; Shenoy, G. Curr. Drug Metab. 2014, 15, 389−397. [Google Scholar] [Crossref]

20. Chu, X. M.; Wang, C.; Wang, W. L.; Liang, L. L.; Liu, W.; Gong, K. K.; Sun, Eur. J. Med. Chem. 2019, 166, 206−223. [Google Scholar] [Crossref]

21. El-Saghier, A. M.; Mohamed, M. A.; Abd-Allah, O. A.; Kadry, Med. Chem. Res. 2019, 28, 169−181. [Google Scholar] [Crossref]

22. Bekircan, O.; Menteşe, E.; Ü lker, S.; Kucuk, C. Arch. Pharm. 2014, 347, 387−397. [Google Scholar] [Crossref]

23. Kaproń, B.; Czarnomysy, R.; Wysokiński, M.; Andrys, R.; Musilek, K.; Angeli, A.; Supuran, C. T.; Plech, Med. Chem. 2020, 35, 993−1002. [Google Scholar] [Crossref]

24. Cao, X.; Wang, W.; Wang, S.; Bao, L.Eur. J. Med. Chem. 2017, 139, 718−725. [Google Scholar] [Crossref]

25. Dhiman, N.; Kaur, K.; Jaitak, V. Tetrazoles as Anticancer Agents: A Review on Synthetic Strategies, Mechanism of Action and SAR Studies. Bioorg. Med. Chem. 2020, 28, No. 115599. [Google Scholar] [Crossref]

26. Li, Y. T.; Yao, W. Q.; Zhou, S.; Xu, J. X.; Lu, H.; Lin, J.; Hu, X. Y.; Zhang, S. K. Bioorg. Med. Chem. Lett. 2021, 34, No. 127762. [Google Scholar] [Crossref]

27. Gao, C.; Chang, L.; Xu, Z.; Yan, X. F.; Ding, C.; Zhao, F.; Wu, X.; Feng, L. S. Eur. J. Med. Chem. 2019, 163, 404−412. [Google Scholar] [Crossref]

28. Desai, N. C.; Trivedi, A.; Somani, H.; Jadeja, K. A.; Vaja, D.; Nawale, L.; Khedkar, Synth. Commun. 2018, 485 524 540 DOI: 10.1080/00397911.2017.1410892. [Google Scholar] [Crossref]

29. Naveen, G.; Peerapur, B. J. Clin. Diagn. Res. 2012, 6, 1704−1709. [Google Scholar] [Crossref]

30. Friesner, R. A.; Banks, J. L.; Murphy, R. B.; Halgren, T. A.; Klicic, J. J.; Mainz, D. T.; Repasky, M. P.; Knoll, E. H.; Shelley, M.; Perry, J. K.; Shaw, D. E.; Francis, P.; Shenkin, P. J. Med. Chem. 2004, 47, 1739− 1749. [Google Scholar] [Crossref]

31. Holas, O.; Ondrejcek, P.; Dolezal, Med. Chem. 2015, 30, 629−648. [Google Scholar] [Crossref]

Metrics

Views & Downloads

Similar Articles

© 2026 IJLTEMAS · RSIS International. All rights reserved. ISSN 2278-2540.